News Articles

Displaying 1 through 8 of 62  Next Page >>
 
PARKINSONíS INSTITUTE AND CLINICAL CENTER TO PROVIDE ACCESS TO MOBILE HEALTH TECHNOLOGY FOR ASSESSMENT AND MONITORING OF MOVEMENT DISORDERS
Friday, January 15, 2016
Sunnyvale, CA, January 15, 2016----The Parkinson’s Institute and Clinical Center announces their partnership with Global Kinetics Corporation (GKC) in a pilot program that will provide Institute patients with access to an innovative mobile health technology. The Personal KinetiGraph™ (PKG™) is a wrist-worn device that offers comprehensive,
 
PARKINSONíS INSTITUTE AND CLINICAL CENTER PUBLISHES A REVIEW ON THE STATE OF PARKINSONíS REASEARCH IN NATURE GENETICS
Friday, December 4, 2015
PARKINSON’S INSTITUTE AND CLINICAL CENTER PUBLISHES A REVIEW ON THE STATE OF PARKINSON’S REASEARCH IN NATURE GENETICS Sunnyvale, CA, December 1, 2015----The Parkinson’s Institute and Clinical Center is being recognized for it’s comprehensive analysis of the state of Parkinson’s research in a newly published article in Nature
 
New Director Ancillary Therapeutic Program Joins Parkinsonís Institute and Clinical Center
Thursday, October 15, 2015
Barbara Luedtke joins the Parkinson’s Institute and Clinical Center as the new Director Ancillary Therapeutic Program, October 19, 2015 and brings to the Parkinson’s Institute and Clinical Center over 25 years of experience working with patients with neurological disorders including Parkinson’s disease. Ms. Luedtke’s care model
 
BIOGEN ENTERS COLLABORATION WITH THE PARKINSONíS INSTITUTE AND CLINICAL CENTER
Monday, July 27, 2015
Biogen and the Parkinson’s Institute and Clinical Center announce the formation of a strategic alliance focused on enhancing the understanding of the underlying biology of Parkinson’s disease (PD) and the creation of novel tools and programs that could accelerate research and the development of new PD treatments. The agreement will combine the
 
PARKINSONíS INSTITUTE PHYSICIAN INVITED TO PRESENT AT SAN DIEGO MOVEMENT DISORDER CONFERENCE
Tuesday, June 9, 2015
Sunnyvale, CA, June 9, 2015----The Parkinson’s Institute and Clinical Center located in Sunnyvale, CA, announces that Dr. Rohit Dhall has been invited to deliver a presentation on the evaluation of the extended-release formulation of carbidopa-levodopa (CD-LD, aka IPX066), in relation to individuals living with Parkinson’s disease at the 19th
 
World Parkinsonís Day: Recognizing the Signs and Symptoms of PD, and the Importance of Early Diagnosis
Saturday, April 11, 2015
Dr. Carrolee Barlow, CEO of the Parkinson's Institute, has dedicated her career to improving the treatment, care, and quality of life for people with Parkinson's and their caregivers, and tells us how an early diagnosis and small modifications can greatly affect the progression of the disease and the quality of life for those with Parkinson's. World
 
Volunteers Needed for DISCOVERY-PD Biomarker Study
Friday, April 10, 2015
xxxxxxxxxxxxxxxxxxxxxxxxxx Your Institute and Berg Pharma, LLC are currently conducting a research study called DISCOVERY-PD to identify biomarkers for Parkinson’s disease. DISCOVERY-PD will utilize clinical data and samples obtained by the Parkinson's Institute, along with Berg's Interrogative Biology™ platform, to look for disease
 
Rohit Dhall, MD, MSPH to Join Your Parkinson's Institute
Wednesday, February 18, 2015
Rohit Dhall, MD, MSPH Director of Clinical Studies Movement Disorders Specialist We are pleased to share that Rohit Dhall, MD, MSPH will join your Parkinson’s Institute and Clinical Center later this month as a Movement Disorders Specialist and Director of Clinical Studies. Dr. Rohit Dhall joins the Parkinson’s Institute and Clinical Center
 
Next Page >>
 
675 Almanor Avenue | Sunnyvale, CA 94085
408.734.2800 main | 408.734.8455 fax (Main) | 408.734.9208 fax (Clinic Secure)